They are thinking about GLP-1s
To work around that, two non-oral delivery methods have become popular: IV glutathione - a sterile solution infused directly into a vein Glutathione nasal spray - a fine mist of reduced glutathione delivered into the nasal passages Both routes bypass the digestive system, but they send glutathione into the body in different ways: IV therapy mainly floods the systemic circulation with a high short-term dose
R., Schwarzlmller, T., Brekke, N., Diab, J., Sverkeli, L., Skjeie, V., Varhaug, K., Tysnes, O.-B., Peng, S., Haugarvoll, K., Ziegler, M., Grner, R., Eidelberg, D., & Tzoulis, C
Abscesses are rare and tunnels are exceptional and non-coalescent
NICE guidelines for type 2 diabetes (NG28) recommend reviewing GLP-1 treatment at around 6 months and continuing only if there has been a meaningful reduction in HbA1c (typically at least 11 mmol/mol [1%]) and weight loss of at least 3% of initial body weight